CJ Cheiljedang : Matters Related to Ad Hoc Public Disclosure Obligation (Fair Disclosure)
February 14, 2022 at 02:13 am
Share
Matters Related to Ad Hoc Public Disclosure Obligation (Fair Disclosure)
1. Details of information
Disclosure title
Provide three-year dividend policy(2021-2023) to enhance dividend visibility
Summary of ad-hoc public disclosure
- Payout ratio over 20%(excluding non-recurring profit/loss) of Stand-alone financial statements
- Annual dividends will be determined every year in consideration of investments, financial structure, business environment and stability of dividend
- Introduce Quarterly Dividend : Planning to start from 2022
Expected ad-hoc public disclosure date & time
-
2. Details of information release
Information providers
CJ CheilJedang Corporation
Information recipients
Investors, analysts, journalists, etc.
Date & time of information release
Frequently provided after disclosure
Title and place of event held
-
3. Contact points (department/phone number)
IR team/82-2-6740-3145,2933,2935, 2987
4. Other matters to be factored into investment decisions
- This disclosure is in accordance with board resolution of 'Approval of dividend policy for 2021-2023 business year' on Feb.14, 2022.
- The above dividend policy is subject to change following the business environment and market situation. If there is a change, will re-disclose.
※ Related disclosure
-
Attachments
Original Link
Original Document
Permalink
Disclaimer
CJ Cheiljedang Corporation published this content on 14 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 February 2022 07:12:04 UTC.
CJ CheilJedang Corp is a Korea-based company principally engaged in the food processing. The Company operates its business through three segments. The Food Business segment is engaged in the manufacture and sale of products such as sugar, flour, cooking oil, frozen foods, cooked meat and others. The Biotechnology Business segment manufactures and sells food additives such as nucleic acids, monosodium glutamate (MSG), arginine and others, and feed additives such as lysine, threonine, tryptophan, valine, methionine, and plant high protein, among others. This segment is also engaged in the manufacture and sale of pharmaceuticals. The Logistics Business segment is engaged in the provision of logistics services including contract logistics services, delivery services, overseas logistics services, air forwarding and maritime forwarding services. In addition, this segment is engaged in the construction of factories.